365NEWSX
365NEWSX
Subscribe

Welcome

Independent FDA panel votes to authorize booster shots for Johnson & Johnson vaccine - ABC News

Independent FDA panel votes to authorize booster shots for Johnson & Johnson vaccine - ABC News

Independent FDA panel votes to authorize booster shots for Johnson & Johnson vaccine - ABC News
Oct 15, 2021 1 min, 14 secs

An independent Food and Drug Administration advisory panel on Friday voted to move forward with Johnson & Johnson COVID-19 vaccine boosters.

But for the single shot J&J vaccine, which does not offer as strong protection as the two-shot Pfizer or Moderna vaccines, the panel of independent experts agreed it was appropriate to offer boosters to all recipients and to do so sooner in order to get protection to a comparable level.

That said, other experts also pointed out that J&J is still a vital vaccine because it provides ample protection against severe disease, even if not at the levels of the mRNA vaccines, and is easy to administer with only one shot.

As with Moderna, which the panel voted to authorize for booster shots Thursday, the whole process could conclude next week at the earliest.

Another pertinent debate that the FDA panel took on Friday was the potential benefits of mixing and matching vaccines for booster shots.

The non-peer reviewed study evaluated all three vaccines -- Pfizer, Moderna and J&J -- and found that no matter the booster, all study participants saw a "substantial" uptick in antibody levels after a booster shot.

For now, the process will formally move forward with authorizing additional booster doses of Moderna and Johnson & Johnson shots for those who received the same original vaccine, as was the case with the Pfizer booster authorization.

That panel has scheduled a meeting for next Wednesday and Thursday to discuss boosters for Moderna and Johnson & Johnson.

Summarized by 365NEWSX ROBOTS

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED